Biochemical Response to Interferon-Gamma in Subjects With Specific Gene Mutation in Chronic Granulomatous Disease

Clinical trial NCT01147042 · TERMINATED

Trial details

NCT number: NCT01147042
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

IFN-Gamma Therapy CGD Gene Mutation CGD Response to IFNg CGD - Chronic Granulomatous Disease Immunodeficiency Disease

Start date: 2010-05-18
Primary completion: 2014-11-14
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.